← FDA Drug Approvals (Drugs@FDA)
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2023-07-31
Drug application
- FDA Application #
ANDA206081- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- Generic name
- Metformin Hydrochloride
- Active ingredients
- METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SUN PHARM
- First approval
- 2023-07-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown